Use of PDE III inhibitors or calcium sensitizers for the treatment of asymptomatic (occult) heart failure

Details for Australian Patent Application No. 2006310997 (hide)

Owner Boehringer Ingelheim Vetmedica GmbH

Inventors Troetschel, Christian; Kleemann, Rainer; Vollmar, Andrea

Agent Davies Collison Cave

Pub. Number AU-A-2006310997

PCT Pub. Number WO2007/054514

Priority 05110689.6 14.11.05 EP

Filing date 8 November 2006

Wipo publication date 18 May 2007

International Classifications

A61K 31/4166 (2006.01)

A61K 31/4439 (2006.01)

A61K 31/444 (2006.01)

A61K 31/50 (2006.01) - Pyridazines

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

26 June 2008 PCT application entered the National Phase

  PCT publication WO2007/054514 Priority application(s): WO2007/054514

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006310999-Productivity augmenting protein factor, novel cell lines and uses thereof

2006310988-Films and capsules made from modified carboxymethycellulose materials and methods of making same